TEXAS: A new clinical study published in the journal Pharmacology and by the National Institute of Health has found that cannabis is effective in treating Crohn’s disease, which is a form of inflammatory bowel disease (IBD).
IBDs such as ulcerative colitis and Crohn’s affect over a million people in the United States. Many IBD victims suffer from pain, diarrhea and poor ability to digest food, and up to half of IBD cases are so severe that they ultimately require surgery to remove the affected bowel segment.
The study, entitled: “Cannabis Finds Its Way into Treatment of Crohn’s Disease” is co-authored by Rudolf Schicho, PhD and M. Storr, both of the Institute of Experimental and Clinical Pharmacology, Medical University of Graz in Graz, Austria.
In the study abstract, Schicho and Storr note that in ancient medicine, cannabis was widely used to treat and cure bowel disturbances and inflammation, and a recent clinical study now shows that the medicinal herb Cannabis sativa lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.